NeuroSense Therapeutics Ltd. Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019
NeuroSense Therapeutics Ltd. (NRSN) had Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 of $2.32 per share as of 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 · last filed 2024-04-04
- 2023-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $2.32.
- 2022-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $1.64.
| Period end | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 |
|---|---|
| 2023-12-31 | $2.32 20-F · filed 2024-04-04 |
| 2022-12-31 | $1.64 20-F · filed 2024-04-04 |